UiPath Inc. (NYSE:PATH) Position Lessened by AtonRa Partners

AtonRa Partners cut its stake in UiPath Inc. (NYSE:PATH) by 12.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 20,696 shares of the healthcare company’s stock after selling 3,068 shares during the period. AtonRa Partners’ holdings in UiPath were worth $514,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently added to or reduced their stakes in the stock. HighMark Wealth Management LLC bought a new position in shares of UiPath during the 4th quarter valued at about $27,000. Cypress Capital Management LLC WY acquired a new stake in UiPath during the fourth quarter valued at $29,000. Fifth Third Bancorp grew its position in UiPath by 2,005.3% in the third quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock worth $34,000 after acquiring an additional 1,905 shares in the last quarter. GAMMA Investing LLC acquired a new stake in shares of UiPath in the fourth quarter worth about $36,000. Finally, FNY Investment Advisers LLC acquired a new position in UiPath during the fourth quarter valued at approximately $40,000. 62.50% of the stock is currently owned by institutional investors.

UiPath Trading Up 1.6 %

NYSE PATH traded up $0.31 during trading hours on Monday, hitting $19.77. The company’s stock had a trading volume of 4,752,185 shares, compared to its average volume of 8,654,434. UiPath Inc. has a 52 week low of $12.38 and a 52 week high of $27.87. The company has a market capitalization of $11.25 billion, a PE ratio of -116.29 and a beta of 0.96. The company’s 50-day simple moving average is $22.08 and its two-hundred day simple moving average is $21.64.

UiPath (NYSE:PATH) last issued its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. The company had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. Research analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Buying and Selling

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the business’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $22.84, for a total value of $365,440.00. Following the sale, the chief financial officer now directly owns 87,505 shares in the company, valued at $1,998,614.20. The sale was disclosed in a filing with the SEC, which is accessible through this link. In the last quarter, insiders have sold 72,000 shares of company stock valued at $1,591,360. 31.03% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Canaccord Genuity Group upped their price target on UiPath from $27.00 to $30.00 and gave the company a “buy” rating in a report on Friday, March 15th. Truist Financial reissued a “buy” rating and set a $32.00 price objective on shares of UiPath in a report on Wednesday, March 20th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $29.00 price objective on shares of UiPath in a report on Monday, April 1st. William Blair initiated coverage on UiPath in a research report on Tuesday, January 2nd. They issued an “outperform” rating for the company. Finally, Morgan Stanley upped their price objective on UiPath from $17.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 14th. Nine research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $27.41.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.